International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18

Hepatology

Volumn 55, Issue 4, 2012, Pages 1122-1129

  Chie, Wei Chu ^a   Blazeby, Jane M ^b   Hsiao, Chin Fu ^c   Chiu, Herng Chia ^d   Poon, Ronnie T ^e   Mikoshiba, Naoko ^f   Al Kadhimi, Gillian ^g   Heaton, Nigel ^g   Calara, Jozer ^g   Collins, Peter ^h   Caddick, Katharine ^h   Costantini, Anna ⁱ   Vilgrain, Valerie ^j,k   Trinquart, Ludovic ^l   Chiang, Chieh ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f UNIVERSITY OF TOKYO   (Japan)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j BEAUJON HOSPITAL   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l HÔTEL DIEU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SWELLING; ADULT; ARTICLE; CANCER FATIGUE; CANCER PATIENT; CANCER SURGERY; CHEMOEMBOLIZATION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE C30; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE HEPATOCELLULAR CARCINOMA 18; FEMALE; HUMAN; INTERNAL CONSISTENCY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SEXUAL BEHAVIOR; SYSTEMIC THERAPY; TEST RETEST RELIABILITY; TUMOR ABLATION; VALIDATION STUDY; VALIDITY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; EUROPE; FEMALE; HEPATECTOMY; HUMANS; INTERNATIONAL COOPERATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84859155440     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24798     Document Type: Article

References (19)

1. International Agency for Research on Cancer, 2006. Available at:. Accessed on 13 December 2011.
2. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006; 23: 1535-1547.
3. Masaki T, Morishita A, Kurokohchi K, Kuriyama S. Multidisciplinary treatment of patients with hepatocellular carcinoma. Expert Rev Anticancer Ther 2006; 6: 1377-1384.
4. Freeman RB, Jr. Transplantation for hepatocellular carcinoma: the Milan criteria and beyond. Liver Trans 2006; 12(Suppl 2): S8-S13.
5. Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene 2006; 25: 3866-3884.
6. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et.al. Sorafenib in advanced hepatocellular carcinoma. New Engl J Med 2008; 359: 378-390.
7. Cheng AL, Kang TK, Chen Z, Tsao TJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenic in paients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25-34.
8. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711.
9. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
10. Cella DF, Tusky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
11. Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol 2002; 20: 2229-2239.
12. Blazeby JM, Currie E, Zee BCY, Chie WC, Poon RT, Garden OJM, et al. Development of a questionnaire to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer 2004; 40: 2439-2444.
13. American Association for the Study of Liver Disease (AASLD) Guidelines. Available at: and. Accessed on 13 December 2011.
14. Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organisation for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993; 2: 287-295.
15. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual, 3rd ed. Brussels: European Organization for Research and Treatment of Cancer; 2001. EORTC Quality of Life Group.
16. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
17. Streiner DL, Norman GR. Health Measurement Scales (4th ed.). Oxford, UK: Oxford University Press; 2008: 167-210.
18. Tabachnik BG, Fidell LS. Using multivariate statistics (5th ed.). London: Harper & Row; 2006: 570.
19. Fan SY, Eiser C, Ho MC. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol 2010; 8: 559-564.